期刊文献+

NLRP3信号通路在胰腺癌发生发展中的作用机制研究进展

Research progress of NLRP3 signal pathway in the genesis and development of pancreatic cancer
下载PDF
导出
摘要 胰腺癌是目前消化道肿瘤中预后极差的实体恶性肿瘤,其发生和发展的机制仍不十分明确。NOD样受体蛋白3(NLRP3)是一类在细胞质中发挥作用的模式识别受体,可诱导凋亡相关斑点样蛋白(ASC)寡聚化,并通过活化半胱氨酸蛋白酶-1(Caspase-1),介导炎症相关分子白细胞介素1β(IL-1β)和白细胞介素18(IL-18)的成熟释放和细胞焦亡,从而调控炎症反应和肿瘤的发生发展。NLRP3、ASC、Caspase-1、IL-1β及IL-18与胰腺癌的发生和发展密切相关。了解NLRP3信号通路在胰腺癌发生发展中的作用机制,对于发展新的治疗策略和改善患者的预后具有重要意义。
作者 郑立平 沈亦钰 胡春东 陈徐艰 费发明 王兢 ZHENG Liping;SHEN Yiyu;HU Chundong;CHEN Xujian;FEI Faming;WANG Jing
出处 《肝胆胰外科杂志》 2024年第1期50-54,共5页 Journal of Hepatopancreatobiliary Surgery
基金 嘉兴市科技计划项目(2021AD30091)。
  • 相关文献

参考文献15

二级参考文献61

  • 1Jemal A,Thomas A,Murray T,et al.Cancer statistics 2002[J].CA Cancer J Clin,2002,45(52):23-47. 被引量:1
  • 2Lillemoe K D.Currentmanagement of pancreatic carcinoma[J].Ann Surg,1995,91(221):133-148. 被引量:1
  • 3Storniolo A M,Enas N H,Brown C A,et al.An investigational newdrug treatment programfor patients with gemcitabine:results for over 3000 patients with pancreatic carcinoma[J].Cancer,1999,87(85):1261-1268. 被引量:1
  • 4Arends J J,Sleeboom H P,Leys M B,et al.A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinoma[J].Br J Cancer,2005,92(3):445-448. 被引量:1
  • 5Amdhya S,Nelson D L.NF-kappa B signaling and human disease[J].Curr Opin Genet Dev,200l,65(ll):300-306. 被引量:1
  • 6Chen J,Ouyang Z G,Zhang S H,et al.Down-regulation of the nuclear factor-kappa B by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth[J].Oncol Rep,2007,17(6):1445-1451. 被引量:1
  • 7Huang Q,Shen H M,Ong C N.Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factorkappa B[J].Biochem Pharmacol,2004,68(2):361-371. 被引量:1
  • 8Bentires-Alj M,Barbu V,Fillet M,et al.NF-kappa B transcription factor induces drug resistance through MDR1 expression in cancer cells[J].Oncogene,2003,22(23):90-97. 被引量:1
  • 9Banerjee S,Kaseb A O,Wang Z.Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer[J].Cancer Res,2009,69(13):5575-5583. 被引量:1
  • 10Kunnumakkara A B,Guha S,Krishnan S,et al.Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation,angiogenesis,and inhibition of nuclear factor-kappa B-regulated gene products[J].Cancer Res,2007,67(8):3853-3861. 被引量:1

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部